David Tosh is a Professor in the Department of Life Sciences at the University of Bath. His research focuses on cellular reprogramming, developmental biology, and regenerative medicine, with applications to cancer and stem cell therapy. He leads a lab investigating cell type conversions (e.g., pancreatic to liver cells) and their implications for disease like Barrett’s metaplasia. Current lab members include Heather Bone, Christopher Brimson, Zoe Burke, and others listed in the text. He collaborates on projects such as the NextGen-O2k High-Resolution Respirometry initiative and contributes to animal-free 3D tissue modeling. Key research themes include understanding transcription factors driving cell fate decisions, translational applications of reprogramming for therapy, and links between cellular plasticity and cancer progression. His work aligns with UN Sustainable Development Goals related to health and innovation.
Hye-Chung Kum is a Professor in the Department of Health Policy & Management at Texas A&M University, where she pioneers Population Informatics to transform digital data into evidence-based health policy solutions. Her work bridges computer science, public health, and social work to address critical data challenges in healthcare systems. Education: PhD, University of North Carolina at Chapel Hill (UNC-CH), 2004 MSW (Master of Social Work), UNC-CH, School of Social Work, 1998 MS, UNC-CH, Department of Computer Science, 1997 BS, Yonsei University, Seoul, Korea, Department of Computer Science, 1995 Research Vision: Dr. Kum develops privacy-preserving human-computer hybrid systems for cleaning and integrating chaotic real-world data (e.g., EHRs, administrative records). Her Population Informatics framework enables ethical large-scale analysis while addressing data genocide in marginalized communities through innovations like the Secure Decoupled Linkage (SDLink) system. Publication Trends: Recent work (2024-2025) reveals three dominant threads: (1) Mental health service utilization dynamics during/post-pandemic, (2) Racial/ethnic disparities in emergency department use and cancer outcomes, and (3) Ethical data sharing frameworks for vulnerable populations. Her Texas-focused studies on Medicaid payment models and AI-driven record linkage demonstrate practical policy applications. Research Infrastructure: As director of the Population Informatics Lab, she leads cross-disciplinary teams developing Privacy-by-Design tools that balance public health needs with data sovereignty—particularly for American Indian and Alaska Native communities. Her grant-funded work consistently addresses Medicaid transformation and healthcare cost drivers through secondary data analytics.
Syma Iqbal, MD, is an Associate Professor of Clinical Medicine at the University of Southern California's Keck School of Medicine and Norris Comprehensive Cancer Center. She holds leadership roles as Medical Director for Inpatient Services at Norris Cancer Hospital, Medical Director of Ambulatory Services/Infusion Center, and Associate Cancer Physician in Chief. Dr. Iqbal chairs the Norris Clinical Investigations Committee and is a national thought leader in systemic therapy for esophageal and gastric cancers, including roles as co-Chair of the Southwest Oncology Group Esophago-Gastric Committee and Chair of the National Cancer Institute’s Esophago-Gastric Task Force. Dr. Iqbal graduated from the Keck School of Medicine of USC in 1995 and completed a Hematology and Oncology Fellowship in 2001. Her research focuses on clinical trials for gastrointestinal malignancies, pharmacogenomics in colorectal cancer, and molecular markers for treatment response and survival. Key publications highlight anti-HER2 therapies, PD-1 inhibitors, and genomic profiling in oncology. Her clinical trials span phase I-III studies in gastric, esophageal, colorectal, and pancreatic cancers, emphasizing drug combinations, resistance mechanisms, and biomarker-driven approaches. While no scientific awards are explicitly mentioned, her work has shaped national guidelines through leadership in cancer research consortia.
Dr. Daniel Shu is an Assistant Professor in the Department of Medicine at the University of Maryland School of Medicine and a medical oncologist at the University of Maryland Greenebaum Comprehensive Cancer Center. His clinical expertise encompasses gastrointestinal cancers, including liver, bile duct, gallbladder, pancreas, and colon malignancies. Education: MD from Temple University School of Medicine (2017) Internal Medicine Residency at Johns Hopkins Hospital (2020) Medical Oncology Fellowship at Johns Hopkins Hospital (2024) Dr. Shu's research centers on cancer immunology, with emphasis on adaptive immune responses to malignancies. He employs multiomic techniques including bulk/single-cell RNA sequencing, TCR/BCR sequencing, and imaging mass cytometry to investigate tertiary lymphoid structures in liver cancer immunotherapy. His work bridges clinical oncology and mechanistic immunology to optimize therapeutic strategies. His 2024-2025 publications reveal a concentrated focus on tertiary lymphoid structures as biomarkers and therapeutic targets in hepatocellular carcinoma. Research spans clinical trial analysis, pathological response assessment, and morphological characterization of immune structures during neoadjuvant immunotherapy, establishing foundational insights for precision immuno-oncology. Scientific Awards: Conquer Cancer/ASCO Young Investigator Award (2024-2025) Supported by the ASCO Young Investigator Award, Dr. Shu leads research integrating clinical oncology with advanced immunological profiling. He actively collaborates within multidisciplinary teams at the Greenebaum Comprehensive Cancer Center, focusing on gastrointestinal malignancies and immune microenvironment dynamics. His ongoing projects include biomarker development for immunotherapy response prediction. As a member of ASCO, AACR, and SITC, Dr. Shu contributes to national cancer research initiatives while maintaining clinical practice in gastrointestinal oncology at the University of Maryland's NCI-designated cancer center.
Dr. Ramazan Kozan is a full-time faculty member in the Department of General Surgery at Gazi University Faculty of Medicine since 2019. His primary affiliations include professional memberships in organizations such as the Turkish Surgical Society, Turkish Society of Colon and Rectal Surgery, and the National Endoscopic Laparoscopic Surgery Society. Colorectal Surgery Pelvic Floor Disorders Robotic & Laparoscopic Surgery da Vinci Robotic Console Surgeon His research focuses on surgical interventions for colorectal diseases, pelvic floor disorders, and robotic laparoscopic techniques. He has contributed to the validation of clinical tools and surgical outcomes in colorectal cancer, and his work includes experimental studies on surgical physiology and postoperative complications. The article trends highlight his expertise in colorectal surgery , minimally invasive techniques , and surgical responses to emerging infectious diseases like SARS-CoV-2. His work bridges clinical practice , experimental research , and cross-disciplinary collaboration in surgical innovation. FACS : Fellow of the American College of Surgeons (2023) FEBS-Coloproctology : European Board Qualification in Colorectal Surgery (2024) He has authored over 40 peer-reviewed publications and actively contributes to editorial and review processes in national surgical journals. His certifications include Endoscopy Training from the Turkish Surgical Society and da Vinci Robotic Console Surgeon accreditation.
Frank K. Jones, MD, MPH, FACS serves as a Clinical Associate Professor in the Department of Surgery at Morehouse School of Medicine, practicing at Grady Memorial Hospital in Atlanta. Board-certified in General Surgery and Wound Management with Surgical Critical Care eligibility, his clinical expertise spans trauma, critical care, and complex hernia management, directly impacting patient outcomes at this Level I trauma center. His educational foundation includes a Bachelor of Science from Morehouse College, Doctor of Medicine from Morehouse School of Medicine, and Master of Public Health from UNC Chapel Hill. Surgical training encompassed dual residencies at Morehouse School of Medicine and Howard University, culminating in a Trauma and Surgical Critical Care fellowship at the University of Maryland. Dr. Jones' research program centers on innovative surgical techniques and critical care interventions, with significant contributions to ventral hernia repair methodologies and nutritional support protocols for trauma patients. His work bridges complex case reporting with translational studies on mortality reduction, establishing him as a key contributor to surgical literature in high-acuity settings. His publication record from 2005-2017 reveals consistent innovation in surgical problem-solving, particularly in hernia pathologies and trauma nutrition. The progression from case reports on rare presentations to clinical studies on vitamin D/glutamine supplementation demonstrates growing influence in evidence-based critical care protocols, with emphasis on practical applications in resource-constrained urban trauma environments. His accolades reflect both clinical excellence and community impact: Georgia's Top Doctor designation (2020, 2021) Atlanta Medical Association Physician of the Year (2018) Morehouse School of Medicine Hall of Fame induction (2017) Employee Diversity Equity and Inclusion Award (2022) Outstanding Humanitarian Award from Hosea Feed the Hungry (2018) While specific graduate student advising details aren't documented, his academic rank and departmental role indicate active mentorship of surgical trainees. His research program appears integrated with Grady Hospital's trauma services, though dedicated laboratory infrastructure isn't referenced in available materials.
Abhijit Mukherjee is a John Curtin Distinguished Professor at Curtin University's School of Civil and Mechanical Engineering within the Faculty of Science and Engineering. He specializes in sustainable engineering practices, structural health monitoring, and infrastructure rehabilitation. His research focuses on developing sustainable materials, assessing infrastructure health using advanced techniques like laser ultrasonics, and mitigating contamination in groundwater systems. Key research projects include the ARC Linkage Project on laser ultrasonic health monitoring (2015) and bacterial-based sustainable materials (2013). He has advised on numerous infrastructure rehabilitation projects, such as the Naini Bridge and Sikkim earthquake rehabilitation (2008–2013). His work bridges structural engineering with environmental science, addressing global challenges like arsenic contamination and climate change impacts on groundwater. Publications span over 200 articles in journals like Environmental Science & Technology, Science of the Total Environment, and Groundwater for Sustainable Development. His research emphasizes machine learning applications, geochemical processes, and policy-driven solutions for water security.
Andrzej Hellmann is a retired Professor from the Faculty of Medicine at the Medical University of Gdańsk. His work focused on hematology, oncology, surgical oncology, and transplantation medicine. He contributed to research on bone marrow and stem cell transplantation, leukemia and lymphoma treatment, and cancer genetics. Research interests include understanding the impact of genetic variations in cancer predisposition, managing complications in kidney and pancreas transplantation, and addressing rare surgical pathologies like ectopic pancreas and Meckel’s diverticulum. He also explored post-pandemic surgical adjustments and the role of biomarkers such as SPINK1 in chronic conditions. Dr. Hellmann has advised 7 promoted theses. His research has been published in over 750 articles, reflecting a strong emphasis on both clinical and translational studies. He holds a MEiN Score of 4,868 and has an associated Scopus profile, indicating extensive academic contributions. No specific scientific awards or grants are listed in the provided texts. Labs or dedicated research teams are not explicitly mentioned in his profile.
Prof. Dr. Semra Günay is a distinguished Professor of General Surgery at Istanbul Okan University Hospital, specializing in Breast Surgery and Endocrine Surgery. She has extensive experience in breast cancer treatment, intraoperative radiotherapy, and oncoplastic surgery techniques. Her clinical work focuses on providing comprehensive care for patients with breast diseases and endocrine disorders. Her educational background includes: Medical degree from Istanbul University Faculty of Medicine Specialized training in Breast Cancer Surgery, Intraoperative Radiotherapy (IORT), and Oncoplastic Surgery at Marian and Luisen Breast Center in Düsseldorf, Germany Prof. Günay's research interests center around breast health and cancer treatment innovations. She has conducted significant work on intraoperative radiotherapy techniques for breast cancer patients, comparing outcomes between different radiation approaches. Her research particularly examines cosmetic results and local recurrence rates following breast-conserving surgery. She also investigates age-related differences in breast cancer presentation and treatment outcomes, with special focus on elderly patients. Her work extends to multidisciplinary approaches in breast cancer diagnosis and management. Her publication record demonstrates a strong focus on breast cancer treatment innovations, particularly in the areas of intraoperative radiotherapy and oncoplastic techniques. She has contributed to national consensus guidelines for breast cancer management during the COVID-19 pandemic, showing her leadership in adapting cancer care to emergency situations. Her work spans clinical research, surgical technique refinement, and multidisciplinary approaches to breast cancer care, with significant contributions to understanding treatment outcomes across different age groups. Prof. Günay has been actively involved in numerous national and international conferences as a speaker and moderator, particularly in the fields of breast surgery and endocrine surgery. She has contributed to book chapters on thyroid and parathyroid diseases and has participated in developing national guidelines for breast cancer management. Her expertise is frequently sought for challenging cases in thyroid and adrenal surgery. She has served in various professional capacities including as a moderator for oncological surgery courses and as a presenter at numerous national surgical congresses. Her work extends to multidisciplinary breast cancer committees where she contributes to comprehensive patient care approaches, emphasizing the importance of collaborative decision-making in complex cancer cases.
Professor Jochen Gaedcke is an active surgical oncology specialist at University Medical Center Göttingen's Faculty of Medicine, Department of Surgery. His supervisory role spans 15 doctoral theses from 2017-2025, demonstrating his sustained academic leadership in gastrointestinal and cancer research. Position: Professor of Surgery Supervision Period: 2017-2025 (ongoing) Thesis Topics: Primarily focused on gastrointestinal malignancies and surgical outcomes Professor Gaedcke's research centers on surgical oncology with particular emphasis on pancreatic and colorectal cancers. His work investigates tumor microenvironment characteristics (particularly fibrosis in pancreatic cancer), molecular mechanisms of treatment response (KRAS mutations, p53 pathways), and clinical outcomes following gastrointestinal procedures. His supervision portfolio reveals a consistent focus on improving diagnostic methods, treatment efficacy, and complication management in visceral surgery. Analysis of his supervised publications shows a strong trend toward translational research bridging basic science discoveries with clinical applications. Approximately 60% of the theses focus on gastrointestinal cancers (pancreatic, colorectal, gastric), 25% on surgical complications and outcomes, and 15% on diagnostic innovations. The work demonstrates increasing sophistication in molecular analysis techniques over time, with recent theses incorporating advanced biomarker discovery and personalized treatment approaches. Professor Gaedcke has supervised 15 doctoral candidates to completion between 2017-2025, indicating a robust mentoring program. His students have investigated diverse aspects of surgical oncology, with several focusing on pancreatic cancer (3 theses), colorectal cancer (4 theses), and diagnostic methods (3 theses). This mentoring activity demonstrates his central role in training the next generation of surgical researchers in Germany. His laboratory work appears to focus on tumor microenvironment analysis, particularly the role of fibrosis in pancreatic cancer progression and treatment response. The collaborative nature of his work is evident from co-authorship on multiple publications with colleagues across pathology, molecular biology, and clinical departments.
Daniel Appelbaum, MD, is a Professor of Radiology at the University of Chicago, specializing in nuclear medicine and molecular imaging. He serves as a radiologist and nuclear medicine physician at the University of Chicago Medicine, where he leads a section involved in multiple oncology PET/CT clinical trials. Dr. Appelbaum chairs the University of Chicago Radioactive Drug Research Advisory Committee (RADRAC) and is an active member of the national Society of Nuclear Medicine Committee on Education. Mallinckrodt Institute of Radiology at Washington University, St. Louis, MO (2000) - Fellowship in Nuclear Medicine University of Chicago, Chicago, IL (1999) - Residency in Diagnostic Radiology Mount Sinai School of Medicine, New York, NY (1995) - MD Cornell University, Ithaca, NY (1991) - BA in English Literature American Board of Radiology Certification (1999) American Board of Nuclear Medicine Certification (2000) Dr. Appelbaum's research focuses on nuclear and molecular imaging in both basic science and clinical settings. His current work includes developing a novel brain imaging agent for multiple sclerosis and a metabolic catalyst to enhance tumor detection with PET imaging. He has pioneered new strategies for computer-aided diagnosis (CAD) in nuclear medicine, for which he holds an AI patent. His research spans oncologic, neurologic, and cardiac applications of PET and PET/CT imaging, with special emphasis on metabolic tumor volume analysis, molecular targeted therapies, and quantitative imaging biomarkers. His laboratory investigates applications of artificial intelligence in radiographic image interpretation, particularly for cancer detection and monitoring treatment response. Analysis of Dr. Appelbaum's recent publications (2015-2025) reveals a strong focus on quantitative nuclear medicine imaging, particularly PET/CT applications in oncology. His work consistently explores metabolic tumor volume as a prognostic marker across various cancers including lung cancer, lymphoma, and neuroendocrine tumors. There is a clear trajectory toward integrating artificial intelligence with nuclear medicine imaging, as evidenced by his research on computer-aided diagnosis systems and quantitative image analysis. His publications span multiple disciplines including oncology, neurology, cardiology, and hematology, demonstrating the broad applicability of nuclear imaging techniques across medical specialties. America's Top Doctor (Castle Connolly, 2014-present) Chicago's Top Doctor (Chicago Magazine, 2012-present) Marc Tetalman Teacher of the Year Award (University of Chicago, 2006-2007) As an educator, Dr. Appelbaum has made significant contributions to nuclear medicine education, serving on the national Society of Nuclear Medicine Committee on Education for many years. He authored the textbook Nuclear Medicine RadCases as a comprehensive review resource for the field. He frequently accepts lecture invitations on nuclear and PET imaging at medical institutions and conferences worldwide. His research program has secured multiple clinical trials funding, particularly in oncology PET/CT applications for monitoring therapy response. Dr. Appelbaum's AI-related patent in computer-aided diagnosis represents a significant translational research achievement with potential clinical impact. Dr. Appelbaum leads a research section at the University of Chicago focused on nuclear and molecular imaging. His team collaborates extensively with oncologists, neurologists, and cardiologists on clinical trials and translational research projects. The group is particularly active in developing novel imaging biomarkers and quantitative analysis methods for cancer imaging. They maintain strong collaborations with computer science researchers for AI development in medical imaging. The section participates in multiple multi-center clinical trials evaluating PET/CT for cancer staging, treatment response assessment, and prognostication across various malignancies.
Andrea Ruzzenente is a Full Professor of General Surgery and Hepatobiliary Surgery at the University of Verona. He serves as the Department Director of Chirurgia Generale ed Epatobiliare and coordinates the PhD Program in Surgical and Cardiovascular Sciences. His clinical and research activities focus on hepatobiliary and pancreatic surgery, with expertise in minimally invasive and robotic techniques for cancer treatment. Education and Roles: Department Director, Chirurgia Generale ed Epatobiliare PhD Coordinator, Surgical and Cardiovascular Sciences Member of multiple academic committees including the Faculty Board and Teaching Committees Research Interests: Clinical and molecular research in hepatobiliary cancers Development of minimally invasive surgical techniques Prognostic modeling in liver surgery Recent Articles: Focus on optimizing outcomes in liver surgery, robotic approaches, and predictive models for postoperative complications. Highlights include studies on hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer. Teaching and Training: Lead instructor for advanced surgical courses (e.g., robotic surgery, minimally invasive techniques) Supervises postgraduate programs in General Surgery and Radiodiagnosis Labs and Teams: Associated with the Lurm Medical Research Laboratory and the Cardiovascular Research Laboratory. Involved in spin-off companies Nutretech S.r.l. and DiSS S.r.l. for translational research applications.
Serkan Kir is an Assistant Professor in the Department of Molecular Biology and Genetics at Koc University. His research focuses on cancer cachexia, metabolism in oncology, and the physiological interactions between adipose tissue and skeletal muscle. He obtained his PhD from UT Southwestern Medical Center (2011) and a Bachelor's degree from Bilkent University (2006). Education: PhD, UT Southwestern Medical Center, 2011 Bachelor's Degree, Bilkent University, 2006 Research Interests: Cancer cachexia, metabolism, and tissue physiology are central themes in his work. He investigates: Mechanisms of tumor-induced muscle wasting Adipose tissue thermogenesis and browning Cytokine signaling (e.g., interleukin-6 family, Oncostatin M) Role of EDA2R-NIK and PTHrP pathways in cachexia Epigenetic and transcriptional regulation in metabolic disorders Therapeutic targeting of HDACs and receptor signaling Recent Publication Trends: His work spans translational cancer biology, metabolic reprogramming during cachexia, and receptor-ligand interactions driving tissue wasting. Key areas include fibroblast growth factor signaling, bile acid metabolism, and interventions for Duchenne muscular dystrophy.
Daniel Oppenheimer, M.D. serves as Associate Professor in the Department of Imaging Sciences at the University of Rochester School of Medicine and Dentistry. He holds dual leadership roles as Division Head of Remote Radiology and member of the Abdominal Imaging Division. Affiliated with the University of Rochester Medical Faculty Group (URMFG) and Accountable Health Partners (AHP), he contributes to a network spanning 19 departments and over 2,000 medical faculty across regional healthcare systems. His academic foundation includes: MD from University of Vermont College of Medicine (2011) Internal Medicine Internship at Eye and Ear Hospital of Pittsburgh (2011-2012) Diagnostic Radiology Residency at University of Rochester Medical Center (2012-2016) Abdominal Imaging Fellowship at Mallinckrodt Institute of Radiology (2016-2017) Dr. Oppenheimer's research pioneers telediagnostic ultrasound for resource-limited settings, notably through Peru-based projects expanding imaging access in rural communities. His work bridges abdominal imaging with remote radiology innovation, covering thyroid diagnostics, hepatobiliary pathology, placental MRI, and venous disease characterization. As an active member of RSNA, ARRS, SAR, SRU, and ASER, he advances clinical protocols through national lectures on diagnostic radiology. His publication trajectory reveals two dominant trends: (1) Telemedicine solutions addressing radiology staffing crises and geographic healthcare disparities, and (2) Precision abdominal imaging techniques enhancing diagnostic accuracy for complex conditions. Recent work demonstrates how remote radiology systems improve workflow efficiency while maintaining diagnostic integrity across diverse clinical scenarios. Professional recognition includes: Certificate of Merit - Excellence in Conference Teaching (2022-2023) Volunteer Service Award (2022) Section Chair's Sub-specialty Award (2018) Magna Cum Laude Award (2018) Shu Ren Lin Faculty Teaching Award (2017-2018) Certificate of Merit (2014) Bernd Heinrich Award for Physiology Research (2007) Presidential Scholar (2004-2006) As a dedicated educator in the Diagnostic Radiology Residency Program, Dr. Oppenheimer integrates his remote radiology expertise into curriculum development while mentoring trainees in abdominal imaging subspecialization. His leadership in the Remote Radiology division has established evidence-based frameworks for tele-radiology implementation, directly influencing departmental staffing models and work-life balance initiatives. Current research collaborations focus on validating telediagnostic systems in global health contexts. He directs the Remote Radiology division while collaborating with multidisciplinary teams across abdominal imaging services. His Peru-based telediagnostic ultrasound projects exemplify commitment to healthcare equity, demonstrating scalable models for expanding imaging access in underserved regions through technology-enabled clinical pathways.
Forrest Smith is a Professor and Director of Graduate Programs at Auburn University 's Harrison College of Pharmacy . He has served in various academic roles since 1987, including Assistant Professor (1987-92), Associate Professor (1992-2019), and Professor (2019-present). B.S. in Biochemistry from Virginia Tech (1980) Ph.D. in Medicinal Chemistry from Virginia Commonwealth University (1985) Postdoctoral Fellowship at University of North Carolina at Chapel Hill (1985-87) His research focuses on medicinal chemistry with expertise in organic synthesis, molecular modeling, and NMR spectroscopy. Key areas include synthetic cannabinoids, DNA alkylators, Tyrosine Kinase Inhibitors, and Ergot alkaloids. Supported by DOJ grants, his work has expanded structure-activity relationship (SAR) knowledge of cannabinoids and developed novel CB2 agonists for analgesic applications. Selected Publications (2016-2024) demonstrate interdisciplinary work in Journal of Leukocyte Biology , AAPS PharmSciTech , and Cancer Research , covering topics from myeloperoxidase inhibition to pan-RAS cancer therapeutics. Current collaborations involve Drug Discovery and Development units at Auburn University. Scientific Contributions include innovations in ocular drug delivery through cyclodextrin complexation, forensic chemistry applications, and neuropharmacological research. He has co-authored over 75 publications across diverse fields including pharmacology, biochemistry, and biomedical analysis.
